In September 2018, Blackrock Microsystems, LLC, a leading neuroscience company, received a loan from Enhanced Capital through the Utah New Markets Tax Credit program. The Company manufactures products to help research institutes and corporations conduct studies to address neuro disorders like paralysis and chronic pain.

Blackrock’s technology has been at the core of worldwide innovations, such as the brain-controlled bionic arm. Capital from Enhanced directly supported the development of a new product in addition to generating full-time engineering and manufacturing jobs. With support from Enhanced, the Company continues to create technical breakthroughs. More information about Blackrock Microsystems.